LifeSteps Financial’s Dr. Reddy's Laboratories RDY Stock Holding History

LifeSteps Financial’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.7K	Buy	+1,221	New	+$16.5K	0.01%	325

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

FRA

Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

LifeSteps Financial's RDY Position: Q2 2026 in Review

LifeSteps Financial opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 1,221 shares worth $17.7K. The stake represents 0.01% of the portfolio and ranks #325 among its holdings.

60 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

LifeSteps Financial held 1,221 shares of Dr. Reddy's Laboratories worth $17.7K as of Q2 2026.
Dr. Reddy's Laboratories was a new LifeSteps Financial position in Q2 2026.
Dr. Reddy's Laboratories made up 0.01% of LifeSteps Financial's portfolio in Q2 2026, its #325 holding.
60 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.